£885.00

The 2026-2031 World Outlook for Antidepressant Drugs

Subjects

Price data last checked 25 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£885 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 66 days · 66 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 66 days • 1 price levels

Days at Price

Price Analysis

Most common price: £885 (66 days, 100.0%)

Price range: £885 - £885

Price levels: 1 different prices over 66 days

Description

This study covers the world outlook for antidepressant drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of antidepressant drugs as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott Laboratories, AstraZeneca, Forest Laboratories, Intra-Cellular Therapies, Janssen Pharmaceuticals, Lupin, Novartis, and OPKO Health. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2025).

Product Specifications

Format: paperback
ASIN: B0FG38PNTB
Category: Books > Subjects
Domain: Amazon UK
Release Date: 04 June 2025
Listed Since: 30 June 2025

The 2026-2031 World Outlook for Antidepressant Drugs

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2026-2031 World Outlook for Antidepressants

The 2026-2031 World Outlook for Antidepressant Pharmaceuticals

The 2021-2026 World Outlook for Antidepressants

The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs

The 2016-2021 Outlook for Antidepressant Pharmaceuticals in Japan

The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in the United States

The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders

The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in China

The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States

The 2021-2026 World Outlook for Major Depressive Disorder (MDD) Therapeutics

The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders for US Zip Codes

The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States

The 2021-2026 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants

The 2026-2031 World Outlook for Antidepressants for Major Depressive Disorders

The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States

Antidepressants: Perspectives, Medical Uses & Health Implications (Pharmacology - Research, Safety Testing and Regualtion)

The 2023-2028 Outlook for Anxiety Disorder Therapeutics in the United States

Effects of Antidepressants

Therapies for Treatment-Resistant Depression: Neuropharmacology and Neurostimulation

The 2016-2021 Outlook for Generic Prescription Drugs in the United States

Diagnostik und Verlauf depressiver Störungen: Differenzierung der Depression - Einbezug von Persönlichkeit und Temperament - multidimensionale Diagnostik

The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in Japan

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

The 2025-2030 World Outlook for Generic Prescription Drugs